|Aangeboden in rubriek:
Hebt u iets om te verkopen?

Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mul..

Objectstaat:
Nieuw
Prijs:
US $39,98
OngeveerEUR 37,41
Verzendkosten:
US $4,99 (ongeveer EUR 4,67) Voordelige verzending. Details bekijkenvoor verzending
Bevindt zich in: Fairhope, Alabama, Verenigde Staten
Levering:
Geschatte levering tussen vr, 21 jun en ma, 24 jun tot 43230
Bij geschatte leveringsdatums - nieuw venster of tabblad wordt rekening gehouden met de verwerkingstijd van de verkoper, de postcode van de verzendlocatie, de postcode van de bestemming, en het moment van aanvaarding. Geschatte leveringsdatums zijn ook afhankelijk van de geselecteerde verzendservice en de ontvangst van de betalingbetaling ontvangen - nieuw venster of tabblad. De leveringstermijnen kunnen variëren, vooral gedurende piekperiodes.
Wordt vandaag verzonden als u betaalt binnen 5 uur 18 min. Details bekijkenvoor verzending
Retourbeleid:
30 dagen om te retourneren. Koper betaalt voor retourzending. Details bekijken- voor meer informatie over retourzendingen
Betalingen:
     

Winkel met vertrouwen

Geld-terug-garantie van eBay
Ontvang het object dat u hebt besteld of krijg uw geld terug. 

Verkopergegevens

Geregistreerd als particuliere verkoper, dus de consumentenrechten die voortvloeien uit de EU-wetgeving inzake consumentenbescherming zijn niet van toepassing. De geld-terug-garantie van eBay geldt nog steeds voor de meeste aankopen.
De verkoper neemt de volledige verantwoordelijkheid voor deze aanbieding.
eBay-objectnummer:305561153681
Laatst bijgewerkt op 13 mei 2024 01:45:24 CESTAlle herzieningen bekijkenAlle herzieningen bekijken

Specificaties

Objectstaat
Nieuw: Een nieuw, ongelezen en ongebruikt boek in perfecte staat waarin geen bladzijden ontbreken of ...
Country/Region of Manufacture
United States
ISBN
9780521563086
Subject Area
Medical, History
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Item Length
9.3 in
Publisher
Cambridge University Press
Subject
United States / 20th Century, Preventive Medicine
Publication Year
1996
Type
Textbook
Format
Hardcover
Language
English
Item Height
0.8 in
Author
Louis P. Galambos
Item Width
6.2 in
Item Weight
18.6 Oz
Number of Pages
320 Pages

Over dit product

Product Information

Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.

Product Identifiers

Publisher
Cambridge University Press
ISBN-10
0521563089
ISBN-13
9780521563086
eBay Product ID (ePID)
469095

Product Key Features

Author
Louis P. Galambos
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Format
Hardcover
Language
English
Subject
United States / 20th Century, Preventive Medicine
Publication Year
1996
Type
Textbook
Subject Area
Medical, History
Number of Pages
320 Pages

Dimensions

Item Length
9.3 in
Item Height
0.8 in
Item Width
6.2 in
Item Weight
18.6 Oz

Additional Product Features

As Told to
Sewell, Jane Eliot
Lc Classification Number
Rm281.G35 1997
Reviews
'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal, "Galambos and Sewell's well-documented book is a valuable and unusual contribution to the history of specialized pharmaceutical endeavor in America, with emphasis on the networking required on the long road leading to each new vaccine." Glenn Sonnedecker, American Historical Review, 'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.'John Hunt, The Pharmaceutical Journal, ‘The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.’John Hunt, The Pharmaceutical Journal, "...best described by its subtitile because of the narrow focus on the chronological history of Merck's vaccine unit." Book Reviews, "Rigorously researched and crisply written, Networks of Innovation....makes a strong case for science-based firms' building and sustaining organizational capabilities to achieve technological innovation as well as to accomodate shifting competitive and regulatory environments." David B. Sicilia, The Journal of American History, "...this is a most impressive work....superb at showing the requisites for successful vaccine innovation. It provides outside observers rare insight into decision making processes at a leading pharmaceutical firm." Marvin Fischbaum, H-Net Reviews, "Networks of Innovation deserves a careful and thoughtful reading by historians of technology because it shows how it is possible to analyze effectively the role of individuals in the process of technological change without losing the insights and rigor that come from sociological and economic theory." W. Bernard Carlson, Technology and Culture
Table of Content
Preface; 1. 1894: 'The foremost medical question of the day'; 2. The Mulford story; 3. A Sharp & Dohme interlude; 4. The virology network and a new programme at Merck, Sharp & Dohme; 5. Hilleman's innovations: first phase, measles-mumps-rubella; 6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama; 7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae; 8. New networks, new leadership: the Hepatitis B vaccines; 9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations; A word about sources.
Target Audience
Trade
Dewey Decimal
615.1/9/00973
Dewey Edition
21
Illustrated
Yes

Objectbeschrijving van de verkoper

Morebks2

Morebks2

100% positieve feedback
7,4K objecten verkocht
Reageert meestal binnen 24 uur

Gedetailleerde verkopersbeoordelingen

Gemiddelde van de afgelopen 12 maanden

Nauwkeurige beschrijving
5.0
Redelijke verzendkosten
5.0
Verzendtijd
5.0
Communicatie
5.0
Geregistreerd als particuliere verkoper
Dus de consumentenrechten die voortvloeien uit EU-wetgeving voor consumentenbescherming zijn niet van toepassing. eBay-kopersbescherming geldt nog steeds voor de meeste aankopen.

Feedback verkoper (2.530)

s***n (3061)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
Perfect! Thank you!
0***k (107)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
Arrived in perfect condition with its shrink wrap still on.
e***r (1728)- Feedback gegeven door koper.
Afgelopen maand
Geverifieerde aankoop
GREAT